Literature DB >> 25517681

Limited in vivo production of type I or type III interferon after infection of macaques with vaccine or wild-type strains of measles virus.

Rupak Shivakoti1, Debra Hauer, Robert J Adams, Wen-Hsuan W Lin, William Paul Duprex, Rik L de Swart, Diane E Griffin.   

Abstract

The innate immune response to viral infections often includes induction of types I and III interferons (IFNs) and production of antiviral proteins. Measles is a severe virus-induced rash disease, but in vitro studies suggest that in the absence of defective interfering RNAs, neither wild-type (WT) nor vaccine strains of measles virus (MeV) induce IFN. To determine whether IFN is produced in vivo, we studied tissues from macaques infected with vaccine or WT strains of MeV using quantitative reverse transcriptase-polymerase chain reaction to assess levels of IFN and IFN-stimulated gene (ISG) mRNAs and a flow cytometry-based bioassay to assess levels of biologically active IFN. There was little to no induction of type I IFN, type III IFN, Mx, or ISG56 mRNAs in monkeys infected with vaccine or WT MeV and no IFN detection by bioassay. Therefore, the innate responses to infection with vaccine or WT strains of MeV are not dependent on IFN production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25517681      PMCID: PMC4390142          DOI: 10.1089/jir.2014.0122

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  47 in total

1.  IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

Authors:  Sergei V Kotenko; Grant Gallagher; Vitaliy V Baurin; Anita Lewis-Antes; Meiling Shen; Nital K Shah; Jerome A Langer; Faruk Sheikh; Harold Dickensheets; Raymond P Donnelly
Journal:  Nat Immunol       Date:  2002-12-16       Impact factor: 25.606

2.  Growth of measles virus in epithelial and lymphoid tissues of cynomolgus monkeys.

Authors:  M Sakaguchi; Y Yoshikawa; K Yamanouchi; T Sata; K Nagashima; K Takeda
Journal:  Microbiol Immunol       Date:  1986       Impact factor: 1.955

3.  Effect of measles vaccine on immunologic responsiveness.

Authors:  P Fireman; G Friday; J Kumate
Journal:  Pediatrics       Date:  1969-02       Impact factor: 7.124

4.  Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production.

Authors:  D Naniche; A Yeh; D Eto; M Manchester; R M Friedman; M B Oldstone
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor.

Authors:  N Ono; H Tatsuo; Y Hidaka; T Aoki; H Minagawa; Y Yanagi
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Diagnosis of measles by fluorescent antibody and culture of nasopharyngeal secretions.

Authors:  M F Smaron; E Saxon; L Wood; C McCarthy; J A Morello
Journal:  J Virol Methods       Date:  1991-06       Impact factor: 2.014

Review 7.  Novel functions of proteins encoded by viral stress-inducible genes.

Authors:  Saumendra N Sarkar; Ganes C Sen
Journal:  Pharmacol Ther       Date:  2004-09       Impact factor: 12.310

8.  Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells.

Authors:  Eliana M Coccia; Martina Severa; Elena Giacomini; Danièle Monneron; Maria Elena Remoli; Ilkka Julkunen; Marina Cella; Roberto Lande; Gilles Uzé
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

9.  Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles.

Authors:  V G Tamashiro; H H Perez; D E Griffin
Journal:  Pediatr Infect Dis J       Date:  1987-05       Impact factor: 2.129

10.  Global control and regional elimination of measles, 2000-2012.

Authors:  Robert T Perry; Marta Gacic-Dobo; Alya Dabbagh; Mick N Mulders; Peter M Strebel; Jean-Marie Okwo-Bele; Paul A Rota; James L Goodson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-02-07       Impact factor: 17.586

View more
  9 in total

Review 1.  Measles Vaccine.

Authors:  Diane E Griffin
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

2.  Plasma Cytokines and Chemokines in Zambian Children With Measles: Innate Responses and Association With HIV-1 Coinfection and In-Hospital Mortality.

Authors:  Wen-Hsuan W Lin; Ashley N Nelson; Judith J Ryon; William J Moss; Diane E Griffin
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

3.  PACT- and RIG-I-Dependent Activation of Type I Interferon Production by a Defective Interfering RNA Derived from Measles Virus Vaccine.

Authors:  Ting-Hin Ho; Chun Kew; Pak-Yin Lui; Chi-Ping Chan; Takashi Satoh; Shizuo Akira; Dong-Yan Jin; Kin-Hang Kok
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

Review 4.  Understanding the causes and consequences of measles virus persistence.

Authors:  Diane E Griffin; Wen-Hsuan W Lin; Ashley N Nelson
Journal:  F1000Res       Date:  2018-02-28

5.  A durable protective immune response to wild-type measles virus infection of macaques is due to viral replication and spread in lymphoid tissues.

Authors:  Wen-Hsuan W Lin; Eileen Moran; Robert J Adams; Robert E Sievers; Debra Hauer; Steven Godin; Diane E Griffin
Journal:  Sci Transl Med       Date:  2020-04-01       Impact factor: 17.956

Review 6.  The Immune Response in Measles: Virus Control, Clearance and Protective Immunity.

Authors:  Diane E Griffin
Journal:  Viruses       Date:  2016-10-12       Impact factor: 5.048

7.  Evolution of T Cell Responses during Measles Virus Infection and RNA Clearance.

Authors:  Ashley N Nelson; Nicole Putnam; Debra Hauer; Victoria K Baxter; Robert J Adams; Diane E Griffin
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

8.  Modeling the measles paradox reveals the importance of cellular immunity in regulating viral clearance.

Authors:  Sinead E Morris; Andrew J Yates; Rik L de Swart; Rory D de Vries; Michael J Mina; Ashley N Nelson; Wen-Hsuan W Lin; Roger D Kouyos; Diane E Griffin; Bryan T Grenfell
Journal:  PLoS Pathog       Date:  2018-12-28       Impact factor: 6.823

Review 9.  Measles immunity and immunosuppression.

Authors:  Diane E Griffin
Journal:  Curr Opin Virol       Date:  2020-09-04       Impact factor: 7.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.